Compton Wealth Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.79M | Sell |
15,094
-1
| -0% | -$215 | 0.76% | 28 |
|
|
2026
Q1 | $3.25M | Buy |
15,095
+3,256
| +28% | +$722K | 0.72% | 30 |
|
|
2025
Q4 | $2.71M | Buy |
11,839
+70
| +0.6% | +$15.9K | 0.59% | 33 |
|
|
2025
Q3 | $2.73M | Buy |
11,769
+202
| +2% | +$41.1K | 0.63% | 33 |
|
|
2025
Q2 | $2.15M | Buy |
11,567
+119
| +1% | +$22.1K | 0.54% | 35 |
|
|
2025
Q1 | $2.4M | Buy |
11,448
+42
| +0.4% | +$8.16K | 0.67% | 31 |
|
|
2024
Q4 | $2.03M | Sell |
11,406
-221
| -2% | -$40.6K | 0.52% | 40 |
|
|
2024
Q3 | $2.3M | Sell |
11,627
-83
| -0.7% | -$15.5K | 0.58% | 37 |
|
|
2024
Q2 | $2.01M | Buy |
11,710
+452
| +4% | +$74.9K | 0.54% | 40 |
|
|
2024
Q1 | $2.05M | Buy |
11,258
+102
| +0.9% | +$17.6K | 0.56% | 40 |
|
|
2023
Q4 | $1.73M | Buy |
11,156
+1,155
| +12% | +$168K | 0.54% | 40 |
|
|
2023
Q3 | $1.49M | Buy |
10,001
+65
| +0.7% | +$9.54K | 0.51% | 37 |
|
|
2023
Q2 | $1.34M | Sell |
9,936
-179
| -2% | -$26.2K | 0.45% | 41 |
|
|
2023
Q1 | $1.61M | Buy |
10,115
+5,982
| +145% | +$915K | 0.56% | 38 |
|
|
2022
Q4 | $668K | Buy |
4,133
+100
| +2% | +$15.3K | 0.26% | 61 |
|
|
2022
Q3 | $541K | Sell |
4,033
-84
| -2% | -$12.1K | 0.23% | 64 |
|
|
2022
Q2 | $630K | Buy |
4,117
+260
| +7% | +$39.7K | 0.27% | 65 |
|
|
2022
Q1 | $625K | Buy |
3,857
+1,255
| +48% | +$182K | 0.24% | 71 |
|
|
2021
Q4 | $352K | Sell |
2,602
-172
| -6% | -$20.3K | 0.15% | 68 |
|
|
2021
Q3 | $299K | Buy |
2,774
+18
| +0.7% | +$2.06K | 0.14% | 67 |
|
|
2021
Q2 | $310K | Buy |
2,756
+18
| +0.7% | +$2.03K | 0.14% | 66 |
|
|
2021
Q1 | $296K | Buy |
2,738
+27
| +1% | +$2.89K | 0.17% | 68 |
|
|
2020
Q4 | $290K | Sell |
2,711
-357
| -12% | -$34.3K | 0.18% | 64 |
|
|
2020
Q3 | $269K | Buy |
3,068
+409
| +15% | +$38.5K | 0.2% | 60 |
|
|
2020
Q2 | $261K | Buy |
2,659
+27
| +1% | +$2.38K | 0.28% | 58 |
|
|
2020
Q1 | $200K | Buy |
2,632
+200
| +8% | +$17K | 0.26% | 52 |
|
|
2019
Q4 | $215K | Sell |
2,432
-10,740
| -82% | -$892K | 0.19% | 54 |
|
|
2019
Q3 | $997K | Sell |
13,172
-786
| -6% | -$53.9K | 0.55% | 37 |
|
|
2019
Q2 | $1.01M | Hold |
13,958
| – | – | 0.52% | 34 |
|
|
2019
Q1 | $1.13M | Hold |
13,958
| – | – | 0.6% | 32 |
|
|
2018
Q4 | $1.29M | Buy |
+13,958
| New | +$1.23M | 0.66% | 23 |
|
Other funds holding ABBV
Compton Wealth Advisory Group's ABBV Position: Q2 2026 in Review
Compton Wealth Advisory Group reduced its AbbVie (ABBV) stake by 0.01% in Q2 2026, selling an estimated $215 and leaving 15,094 shares worth $3.79M. The position accounts for 0.76% of the portfolio, ranked #28.
Compton Wealth Advisory Group first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Compton Wealth Advisory Group held 15,094 shares of AbbVie worth $3.79M as of Q2 2026.
- Compton Wealth Advisory Group sold 1 AbbVie share in Q2 2026, an estimated $215.
- AbbVie made up 0.76% of Compton Wealth Advisory Group's portfolio in Q2 2026, its #28 holding.
- Compton Wealth Advisory Group first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Compton Wealth Advisory Group's 13F filing for Q2 2026, filed 21 Jul 2026.